Related Experiment Video
Updated: Feb 11, 2026

siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells
Published on: May 24, 2014
Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer
Thanh Hung Nguyen1, Jan-Michael Kugler2
1Institute of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, Denmark. nth1512@gmail.com.
Abstract:
The Hippo pathway serves as a key barrier for oncogenic transformation. It acts by limiting the activity of the proto-oncogenes YAP and TAZ. Reduced Hippo signaling and elevated YAP/TAZ activities are frequently observed in various types of tumors. Emerging evidence suggests that the ubiquitin system plays an important role in regulating Hippo pathway activity. Deregulation of ubiquitin ligases and of deubiquitinating enzymes has been implicated in increased YAP/TAZ activity in cancer. In this article, we review recent insights into the ubiquitin-mediated regulation of the mammalian Hippo pathway, its deregulation in cancer, and possibilities for targeting the Hippo pathway through the ubiquitin system.
Insights
The Hippo pathway, a cancer suppressor, is regulated by the ubiquitin system. Its deregulation promotes cancer by increasing YAP/TAZ activity, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The Hippo pathway is a critical regulator of cell proliferation and organ size, acting as a tumor suppressor.
- Yeast and TAZ are key downstream effectors of the Hippo pathway; their aberrant activation drives oncogenesis.
- Dysregulation of the Hippo pathway is a common feature in various human cancers.
Purpose of the Study:
- To review the role of the ubiquitin system in regulating the mammalian Hippo pathway.
- To explore the implications of Hippo pathway deregulation in cancer.
- To discuss potential strategies for targeting the Hippo pathway via the ubiquitin system for cancer therapy.
Main Methods:
- Literature review of recent studies on ubiquitin-mediated Hippo pathway regulation.
- Analysis of the role of ubiquitin ligases and deubiquitinating enzymes in Hippo signaling.
- Examination of cancer-related studies involving Hippo pathway components.
Main Results:
- The ubiquitin system extensively modulates Hippo pathway components, including LATS kinases and YAP/TAZ.
- Specific ubiquitin ligases and deubiquitinating enzymes have been identified as key regulators of YAP/TAZ activity.
- Aberrant ubiquitination of Hippo pathway proteins contributes to oncogenic transformation and tumor progression.
Conclusions:
- Ubiquitin-mediated regulation is crucial for maintaining Hippo pathway homeostasis.
- Targeting ubiquitin system components offers a promising avenue for developing novel cancer therapeutics.
- Further research into the ubiquitin-Hippo pathway interplay is warranted for clinical applications.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
cAMP-dependent Protein Kinase Pathways
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
GTPases and their Regulation
Large G-proteins,...

